Labcorp Long-Term Investments 2010-2024 | LH

Labcorp long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Labcorp long-term investments for the quarter ending June 30, 2024 were $0.018B, a 73.96% decline year-over-year.
  • Labcorp long-term investments for 2023 were $0.027B, a 59.06% decline from 2022.
  • Labcorp long-term investments for 2022 were $0.066B, a 7.88% increase from 2021.
  • Labcorp long-term investments for 2021 were $0.061B, a 17.14% decline from 2020.
Labcorp Annual Long-Term Investments
(Millions of US $)
2023 $27
2022 $66
2021 $61
2020 $74
2019 $85
2018 $61
2017 $58
2016 $58
2015 $58
2014 $93
2013 $89
2012 $78
2011 $77
2010 $79
2009 $71
Labcorp Quarterly Long-Term Investments
(Millions of US $)
2024-06-30 $18
2024-03-31 $18
2023-12-31 $27
2023-09-30 $40
2023-06-30 $67
2023-03-31 $66
2022-12-31 $66
2022-09-30 $64
2022-06-30 $58
2022-03-31 $62
2021-12-31 $61
2021-09-30 $62
2021-06-30 $82
2021-03-31 $85
2020-12-31 $74
2020-09-30 $71
2020-06-30 $72
2020-03-31 $67
2019-12-31 $85
2019-09-30 $86
2019-06-30 $87
2019-03-31 $67
2018-12-31 $61
2018-09-30 $58
2018-06-30 $59
2018-03-31 $58
2017-12-31 $58
2017-09-30 $65
2017-06-30 $67
2017-03-31 $58
2016-12-31 $58
2016-09-30 $60
2016-06-30 $62
2016-03-31 $61
2015-12-31 $58
2015-09-30 $62
2015-06-30 $69
2015-03-31 $89
2014-12-31 $93
2014-09-30 $95
2014-06-30 $97
2014-03-31 $87
2013-12-31 $89
2013-09-30 $87
2013-06-30 $88
2013-03-31 $87
2012-12-31 $78
2012-09-30 $81
2012-06-30 $79
2012-03-31 $80
2011-12-31 $77
2011-09-30 $75
2011-06-30 $79
2011-03-31 $83
2010-12-31 $79
2010-09-30 $80
2010-06-30 $71
2010-03-31 $69
2009-12-31 $71
2009-09-30 $75
2009-06-30 $69
2009-03-31 $64
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.078B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
West Pharmaceutical Services (WST) United States $22.428B 43.73
Cooper (COO) United States $22.013B 31.33
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13